Ande M. Rumilla

Dr. Ande M. Rumilla is a distinguished pathologist at Mayo Clinic in Rochester, Minnesota, specializing in Laboratory Medicine and Pathology with a focus on Anatomic Pathology. She holds appointments in the Mayo Clinic College of Medicine and serves as an active researcher and clinician within the Department of Laboratory Medicine and Pathology.

Her educational background includes a BA in Biology from the University of Chicago (1999) and an MD from the University of Illinois College of Medicine at Chicago (2004). She completed her residency training in Anatomic and Clinical Pathology (2008) followed by a fellowship in Molecular Genetic Pathology (2010), all at Mayo Clinic.

Dr. Rumilla's research spans molecular pathology, genetic diagnostics, and precision medicine with particular expertise in cancer genomics, molecular diagnostics, and epigenetic analysis. Her work bridges basic science with clinical applications, focusing on developing and validating molecular assays for improved patient care. She has made significant contributions to understanding tumor mutation burden, BRAF/RAS signaling pathways, and molecular characterization of various cancers.

Her publication record shows a clear trend toward increasingly sophisticated molecular techniques, from traditional pathology to next-generation sequencing, liquid biopsy analysis, and computational approaches to molecular diagnostics. Recent work emphasizes pan-cancer biomarker detection, methylation disorder classification, and validation of clinical molecular assays.

• Young Investigator Award from the Association for Molecular Pathology (2009)

Dr. Rumilla actively contributes to professional societies including the Association for Molecular Pathology (since 2009), College of American Pathologists, United States and Canadian Academy of Pathology, and American Society for Clinical Pathology. She has participated in developing consensus guidelines for cell-free DNA assay validation, demonstrating leadership in establishing standards for molecular diagnostics. Her collaborative research extends across multiple Mayo Clinic departments and external institutions, reflecting the interdisciplinary nature of modern molecular pathology.